Regeneron Pharmaceuticals, Inc.
Marion McCourt (EVP Commercial) sells REGN shares
AI-generated summary
Marion McCourt, EVP Commercial, sold 566 shares of Common Stock directly for $543,504.06 at an average price of $960.25 on November 16, 2026. After these transactions, the insider directly held 10,305 shares. The transactions were executed under a Rule 10b5-1 trading plan adopted on February 17, 2026.
Key facts
- Insider
- Marion McCourt · EVP Commercial
Rule 10b5-1 plan · adopted Feb 17, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | S · open-market saleFootnotes F1, F2 | −44 | $952.79 | $41,922.76 | 10,827 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F3 | −59 | $954.46 | $56,313.14 | 10,768 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1 | −30 | $955.51 | $28,665.30 | 10,738 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1 | −22 | $956.01 | $21,032.22 | 10,716 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F4 | −44 | $958.47 | $42,172.68 | 10,672 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F5 | −66 | $959.46 | $63,324.36 | 10,606 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F6 | −49 | $960.31 | $47,055.19 | 10,557 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F7 | −59 | $961.36 | $56,720.24 | 10,498 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F8 | −41 | $962.44 | $39,460.04 | 10,457 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F9 | −42 | $963.70 | $40,475.40 | 10,415 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1 | −21 | $964.69 | $20,258.49 | 10,394 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1, F10 | −63 | $965.62 | $60,834.06 | 10,331 | Direct |
| Nov 16, 2026 | S · open-market saleFootnotes F1 | −26 | $971.93 | $25,270.18 | 10,305 | Direct |
Footnotes
- F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.
- F2 Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $952.64 to $952.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F3 Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $954.44 to $954.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F4 Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $958.29 to $958.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F5 Represents volume-weighted average price of sales of 66 shares of Company stock on November 16, 2026 at prices ranging from $959.18 to $959.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F6 Represents volume-weighted average price of sales of 49 shares of Company stock on November 16, 2026 at prices ranging from $960.07 to $960.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F7 Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $961.26 to $961.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F8 Represents volume-weighted average price of sales of 41 shares of Company stock on November 16, 2026 at prices ranging from $962.15 to $962.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F9 Represents volume-weighted average price of sales of 42 shares of Company stock on November 16, 2026 at prices ranging from $963.32 to $963.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F10 Represents volume-weighted average price of sales of 63 shares of Company stock on November 16, 2026 at prices ranging from $965.38 to $965.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
More REGN filings
- S-8
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.